Chemical apparatus and process disinfecting – deodorizing – preser – Blood treating device for transfusible blood
Reexamination Certificate
2000-03-31
2003-12-30
Sykes, Angela D. (Department: 3762)
Chemical apparatus and process disinfecting, deodorizing, preser
Blood treating device for transfusible blood
C604S006030, C604S006090, C604S006160, C604S406000, C210S323100, C210S348000, C210S500100, C210S505000
Reexamination Certificate
active
06669905
ABSTRACT:
FIELD OF THE INVENTION
The invention generally relates to the processing of whole blood and its components for storage, fractionation, and transfusion.
BACKGROUND OF THE INVENTION
With the coming of blood component therapy, most whole blood collected today is separated into its clinically proven components for storage and administration. The clinically proven components of whole blood include, e.g., red blood cells, which can be used to treat chronic anemia; plasma, which can be used as a blood volume expander or which can be fractionated to obtain Clotting Factor VIII-rich cryoprecipitate for the treatment of hemophilia; and concentrations of platelets, used to control thrombocytopenic bleeding.
Along with the growing demand for these blood components, there is also a growing expectation for purity of the blood product. For example, it is believed beneficial that plasma used for transfusion or fractionation be as free as possible of cellular blood species, such as leukocytes, red blood cells, platelets. For example, European Council Guidelines dictate that fresh frozen plasma should contain less than 6.0×10
9
residual red blood cells per liter, less than 0.1×10
9
residual leukocytes per liter, and less than 50×10
9
residual platelets per liter. There is therefore a growing demand for blood processing and storage systems that can treat plasma in a way that removes virtually all cellular blood species.
As another example, the use of photodynamic therapy has been suggested as a way to eradicate infectious agents from collected blood and its components. Still, not all biological contaminants are carried free within the blood where they can be readily coupled to photoactive agents. Some biological contaminants are entrained on or within blood cell species that the plasma carries. It is therefore desirable to remove these blood cell species from plasma for this reason.
SUMMARY OF THE INVENTION
The invention provides systems and methods for harvesting plasma that is free or virtually free of cellular blood species.
The systems and methods use tubing adapted to be coupled to a source of plasma. A filter is located in the tubing to separate targeted cellular blood species, such as red blood cells and platelets, from plasma that is conveyed from the source. The filter includes first and second hydrophilic polyvinylidene fluoride (PVDF) membranes having pores sized to remove these targeted cellular blood species from plasma by exclusion.
In one embodiment, the filter includes a prefilter layer that also removes aggregates larger than these targeted cellular blood species from plasma.
In one embodiment, the pores of the first PVDF membrane are larger than the pores of the second PVDF membrane. For example, the pores of the first PVDF membrane are about 1.0 &mgr;m in size, and the pores of the second PVDF membrane are about 0.65 &mgr;m in size.
In one embodiment, the first PVDF membrane has a porosity that is characterized by a water bubble point of between about 8.5 psi and 13 psi. In this embodiment, the second PVDF membrane has a porosity that is characterized by a water bubble point of between about 15.5 psi and 20.6 psi.
In one embodiment, the filter includes a flexible housing enclosing the first and second PVDF membranes.
In one embodiment, the filter includes a mesh layer in a downstream flow direction from the first and second PVDF membranes.
Other features and advantages of the invention will be pointed out in, or will be apparent from, the drawings, specification and claims that follow.
REFERENCES:
patent: 3058799 (1962-10-01), Rowles, Jr.
patent: 4786286 (1988-11-01), Cerney et al.
patent: 4790815 (1988-12-01), Balteau et al.
patent: 5100564 (1992-03-01), Pall et al.
patent: 5128048 (1992-07-01), Stewart
patent: 5167656 (1992-12-01), Lynn
patent: 5217627 (1993-06-01), Pall et al.
patent: 5269946 (1993-12-01), Goldhaber et al.
patent: 5283033 (1994-02-01), Dodrill
patent: 5445629 (1995-08-01), Debrauwere et al.
patent: 5451321 (1995-09-01), Matkovich
patent: 5472621 (1995-12-01), Matkovich
patent: 5514106 (1996-05-01), D'Silva
patent: 5601730 (1997-02-01), Page et al.
patent: 5616254 (1997-04-01), Pall et al.
patent: 5695489 (1997-12-01), Japuntich
patent: 5738796 (1998-04-01), Bormann et al.
patent: 5804079 (1998-09-01), Brown
patent: 5804280 (1998-09-01), Pall et al.
patent: 5836934 (1998-11-01), Beshel
patent: 5928214 (1999-07-01), Rubinstein et al.
patent: 5935092 (1999-08-01), Sun et al.
patent: 5941866 (1999-08-01), Niedospial, Jr.
patent: 6051147 (2000-04-01), Bischof
patent: 6190855 (2001-02-01), Herman et al.
patent: 6267745 (2001-07-01), Mathias et al.
Blom Agneta
Mathias Jean Marie
Mespreuve Luc
Payrat Jean-Marc
Vandendaul Daniel
Baxter International Inc.
Bianco Patricia
Mayo Michael
Ryan Daniel D.
Sykes Angela D.
LandOfFree
Systems and methods for collecting plasma that is free or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Systems and methods for collecting plasma that is free or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Systems and methods for collecting plasma that is free or... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3108103